Contraception associated with diabetes risk

Some foods, chemicals and substances are particularly associated with an increased chance of developing type 2 diabetes. A recent study has found that Latino women who have already suffered from pregnancy-related gestational diabetes could be increasing their risk of diabetes by using the contraception depot medroxyprogesterone acetate, sometimes referred to as the leading brand associated with it, Depot Provera.
The study was carried out at the University of Southern California, based in Los Angeles. The experts in charge of the study collated data from a group of just under 530 Latino women who had suffered gestational diabetes and also used depot medroxyprogesterone (DPMA.) The contraceptive is administered in monthly injections. They followed up the cases after initial identification.
Once the data had been adjusted for weight, breast-feeding rate and family history, and for weight gain during follow up, the risk was increased by 7 per cent. Those women who used DPMA and also had higher than average levels of triglycerides in their blood had over 50 per cent chance of developing diabetes. One expert involved in the study was reported as advising breast-feeding mothers to avoid a non-hormonal approach to contraception. Similarly, those mothers who might have high triglycerides levels were advised to avoid DPMA.